AG2202
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AG2202, covering 2024-08-14 to 2024-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence Study of AG2202 [Phase 1]
1 regulatory and trial event tracked for AG2202, covering 2024-08-14 to 2024-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence Study of AG2202 [Phase 1]